Comparison of the expression levels of napsin a, thyroid transcription factor-1, and p63 in nonsmall cell lung cancer using cytocentrifuged bronchial brushings

Cancer Cytopathology

Volumn 119, Issue 5, 2011, Pages 335-345

  Aikawa, Emiko ^a   Kawahara, Akihiko ^a   Hattori, Satoshi ^b   Yamaguchi, Tomohiko ^a   Abe, Hideyuki ^a   Taira, Tomoki ^a   Azuma, Koichi ^c   Kage, Masayoshi ^a  

^a KURUME UNIVERSITY HOSPITAL   (Japan)

^b KURUME UNIVERSITY   (Japan)

^c KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Bronchial brushing cytology; CytoRich Red plus cytospin; Napsin A; Nonsmall cell lung cancer; P63; TTF 1

Indexed keywords

NAPSIN A; PRESERVATIVE; PROTEIN P63; THYROID TRANSCRIPTION FACTOR 1; TUMOR MARKER; UNCLASSIFIED DRUG; ASPARTIC PROTEINASE; NAPSA PROTEIN, HUMAN; NUCLEAR PROTEIN; THYROID NUCLEAR FACTOR 1; TP63 PROTEIN, HUMAN; TRANSCRIPTION FACTOR; TUMOR SUPPRESSOR PROTEIN;

ARTICLE; BRONCHUS BIOPSY; CANCER CELL; CANCER MORPHOLOGY; CELL NUCLEUS; CENTRIFUGATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOCENTRIFUGATION; CYTOLOGY; CYTOPLASM; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; MACROPHAGE; PRIORITY JOURNAL; PROTEIN EXPRESSION; BIOPSY; BIOSYNTHESIS; BRONCHUS; COMPARATIVE STUDY; CYTODIAGNOSIS; LUNG TUMOR; METABOLISM; METHODOLOGY; PATHOLOGY; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY;

ASPARTIC ACID ENDOPEPTIDASES; BIOPSY; BRONCHI; CARCINOMA, NON-SMALL-CELL LUNG; CYTODIAGNOSIS; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; NUCLEAR PROTEINS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TRANSCRIPTION FACTORS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEINS;

EID: 84856397030     PISSN: None     EISSN: 19346638     Source Type: Journal    
DOI: 10.1002/cncy.20162     Document Type: Article

References (31)

1. Kawahara A, Yamamoto C, Nakashima K, et al. Molecular diagnosis of activating EGFR mutations in non-small cell lung cancer using mutation-specific antibodies for immunohistochemical analysis. Clin Cancer Res. 2010;16:3163-3170.
2. Taron M, Ichinose Y, Rosell R, et al. Activating mutations in the tyrosine kinase domain of the epidermal growth factor receptor are associated with improved survival in gefitinib-Treated chemorefractory lung adenocarcinomas. Clin Cancer Res. 2005;11:5878-5885.
3. Kosaka T, Yatabe Y, Endoh H, Kuwano H, Takahashi T, Mitsudomi T. Mutations of the epidermal growth factor receptor gene in lung cancer: biological and clinical implications. Cancer Res. 2004;64:8919-8923.
4. Bishop JA, Sharma R, Illei PB. Napsin A and thyroid transcription factor-1 expression in carcinomas of the lung, breast, pancreas, colon, kidney, thyroid, and malignant mesothelioma. Hum Pathol. 2010;41:20-25.
5. Khayyata S, Yun S, Pasha T, et al. Value of P63 and CK5/6 in distinguishing squamous cell carcinoma from adenocarcinoma in lung fine-needle aspiration specimens. Diagn Cytopathol. 2009;37:178-183.
6. Loo PS, Thomas SC, Nicolson MC, Fyfe MN, Kerr KM. Subtyping of undifferentiated non-small cell carcinomas in bronchial biopsy specimens. J Thorac Oncol. 2010;5: 442-447.
7. Kalhor N, Zander DS, Liu J. TTF-1 and p63 for distinguishing pulmonary small-cell carcinoma from poorly differentiated squamous cell carcinoma in previously papstained cytologic material. Mod Pathol. 2006;19:1117-1123.
8. Wu M, Szporn AH, Zhang D, et al. Cytology applications of p63 and TTF-1 immunostaining in differential diagnosis of lung cancers. Diagn Cytopathol. 2005;33:223-227.
9. Wu M, Wang B, Gil J, et al. p63 and TTF-1 immunostaining. A useful marker panel for distinguishing small cell carcinoma of lung from poorly differentiated squamous cell carcinoma of lung. Am J Clin Pathol. 2003;119:696-702.
10. Jagirdar J. Application of immunohistochemistry to the diagnosis of primary and metastatic carcinoma to the lung. Arch Pathol Lab Med. 2008;132:384-396.
11. Dejmek A, Naucler P, Smedjeback A, et al. Napsin A (TA02) is a useful alternative to thyroid transcription factor-1 (TTF-1) for the identification of pulmonary adenocarcinoma cells in pleural effusions. Diagn Cytopathol. 2007;35:493-497.
12. Ueno T, Linder S, Elmberger G. Aspartic proteinase napsin is a useful marker for diagnosis of primary lung adenocarcinoma. Br J Cancer. 2003;88:1229-1233.
13. Kim S, Owens CL. Analysis of ThinPrep cytology in establishing the diagnosis of small cell carcinoma of lung. Cancer Cytopathol. 2009;117:51-56.
14. Hansen T, Pedersen H, Brauner V, Hariri J. Control specimens for immunocytochemistry in liquid-based cytology. Cytopathology. 2010 [Epub ahead of print].
15. Fan YB, Wang QS, Ye L, Wang TY, Wu GP. Clinical application of the SurePath liquid-based Pap test in cytological screening of bronchial brushing for the diagnosis of lung cancer. Cytotechnology. 2010;62:53-59.
16. Lu DY, Nassar A, Siddiqui MT. High-grade urothelial carcinoma: comparison of SurePath liquid-based processing with cytospin processing. Diagn Cytopathol. 2009;37:16-20.
17. Weidmann J, King LC, Bibbo M. Modification of CytoRich Red fixative system for use on bloody pap and fine-needle aspiration smears. Diagn Cytopathol. 1999;20:95-98.
18. Delavarian Z, Mohtasham N, Mosannen-Mozafari P, Pakfetrat A, Shakeri MT, Ghafoorian-Maddah R. Evaluation of the diagnostic value of a modified liquid-based cytology using OralCDx brush in early detection of oral potentially malignant lesions and oral cancer. Med Oral Patol Oral Cir Bucal. 2010;15:671-676.
19. Jan IS, Chung PF, Weng MH, Huang MS, Lee YT, Kuo SH. Utility of thyroid transcription factor-1 expression in the differential diagnosis of metastatic adenocarcinoma of serous effusion specimens prepared using the cell transfer technique. J Formos Med Assoc. 2006;105:695-700.
20. Allred DC, Harvey JM, Berardo M, Clark GM. Prognostic and predictive factors in breast cancer by immunohistochemical analysis. Mod Pathol. 1998;11:155-168.
21. Nicholson AG, Gonzalez D, Shah P, et al. Refining the diagnosis and EGFR status of non-small cell lung carcinoma in biopsy and cytologic material, using a panel of mucin staining, TTF-1, cytokeratin 5/6, and P63, and EGFR mutation analysis. J Thorac Oncol. 2010;5:436-441.
22. Linder J. Recent advances in thin-layer cytology. Diagn Cytopathol. 1998;18:24-32.
23. Mukhopadhyay S, Katzenstein AL. Subclassification of nonsmall cell lung carcinomas lacking morphologic differentiation on biopsy specimens: utility of an immunohistochemical panel containing TTF-1, napsin A, p63, and CK5/6. Am J Surg Pathol. 2011;35:15-25.
24. Taillade L, Penault-Llorca F, Boulet T, et al. Immunohistochemichal expression of biomarkers: a comparative study between diagnostic bronchial biopsies and surgical specimens of nonsmall-cell lung cancer. Ann Oncol. 2007;18:1043-1050.
25. Viberti L, Papotti M, Abbona GC, et al. Value of Ki-67 immunostaining in preoperative biopsies of carcinomas of the lung. Hum Pathol. 1997;28:189-192.
26. Meert AP, Martin B, Verdebout JM, et al. EGF-R expression correlation between biopsy and surgical specimens of lung carcinoma. Rev Mal Respir. 2003;20:347-353.
27. Meert AP, Martin B, Verdebout JM, et al. Correlation of different markers (p53, EGF-R, c-erbB-2, Ki-67) expression in the diagnostic biopsies and the corresponding resected tumors in non-small cell lung cancer. Lung Cancer. 2004; 44:295-301.
28. Stoll LM, Johnson MW, Gabrielson E, Askin F, Clark DP, Li QK. The utility of napsin-A in the identification of primary and metastatic lung adenocarcinoma among cytologically poorly differentiated carcinomas. Cancer Cytopathol. 2010;118:441-449.
29. Zhang H, Liu J, Cagle PT, Allen TC, Laga AC, Zander DS. Distinction of pulmonary small cell carcinoma from poorly differentiated squamous cell carcinoma: an immunohistochemical approach. Mod Pathol. 2005;18:111-118.
30. Massion PP, Taflan PM, Jamshedur Rahman SM, et al. Significance of p63 amplification and overexpression in lung cancer development and prognosis. Cancer Res. 2003;63:7113-7121.
31. Uke M, Rekhi B, Ajit D, Jambhekar NA. The use of p63 as an effective immunomarker in the diagnosis of pulmonary squamous cell carcinomas on de-stained bronchial lavage cytological smears. Cytopathology. 2010;21:56-63.